During the past decade, Northwest Clinical Research Center conducted 132 clinical trials. In the 10-year time frame, 132 clinical trials started and 102 clinical trials were completed, i.e. on average, 77.3% percent of trials that started reached the finish line to date. In the past 5 years, 58 clinical trials started and 73 clinical trials were completed. i.e. 125.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northwest Clinical Research Center" #1 sponsor was "Eli Lilly and Company" with 32 trials, followed by "Pfizer" with 25 trials sponsored, "Shire" with 17 trials sponsored, "Cephalon" with 11 trials sponsored and "Allergan" with 11 trials sponsored. Other sponsors include 117 different institutions and companies that sponsored additional 66 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northwest Clinical Research Center" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "National Institute on Aging (NIA)" with 2 trials as a collaborator, "PPD" with 2 trials as a collaborator, "Purdue Pharma LP" with 2 trials as a collaborator and "Alder Biopharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Northwest Clinical Research Center" are "Major Depressive Disorder" (29 trials), "Migraine" (16 trials), "Depressive Disorder, Major" (14 trials), "Alzheimer Disease" (9 trials) and "Schizophrenia" (9 trials). Many other conditions were trialed in "Northwest Clinical Research Center" in a lesser frequency.

Most popular intervention types in "Northwest Clinical Research Center" are "Drug" (203 trials), "Biological" (12 trials), "Other" (8 trials), "Device" (5 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (115 trials), "placebo" (10 trials), "Galcanezumab" (9 trials), "Rimegepant" (7 trials) and "Escitalopram" (5 trials). Other intervention names were less common.

The vast majority of trials in "Northwest Clinical Research Center" are 208 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Northwest Clinical Research Center". undefined are not yet recruiting, 27 are recruiting, 10 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 150 completed trials in Northwest Clinical Research Center, undefined suspended trials, and 23 terminated clinical trials to date.

Out of the total trials that were conducted in Northwest Clinical Research Center, 2 "Phase 1" clinical trials were conducted, 69 "Phase 2" clinical trials and 142 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 3 trials that are defined as “Not Applicable".